FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21039711000001104: Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Aug 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70339801000001110 Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70339901000001116 Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Is a Venlafaxine 37.5mg tablets true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Is a Venlafaxine 37.5mg tablets false Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely venlafaxine 37.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has active ingredient Venlafaxine false Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Venlafaxine hydrochloride true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Venlafaxine true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Has basis of strength substance Venlafaxine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) 28 tablet Has AMP True Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) 56 tablet Has AMP True Venlafaxine 37.5mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start